Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "University of Minnesota Medical School"


5 mentions found


AdvertisementSummer is over, and this Sunday it's time to turn back the clocks, ending daylight-saving time for the year. "That's how fragile and susceptible your body is to even just one hour of lost sleep," sleep expert Matthew Walker, author of "How We Sleep," previously told Business Insider. Some lawmakers want permanent DST — others want standard time year-roundThe political debate over DST is fierce, unscientific, and deeply divided. In the 2018 midterms, voters opted to get rid of the annual clock change, to be in permanent daylight-saving time. Switching to permanent DST requires a green light from Congress, but states do not need federal approval to switch to permanent standard time.
Persons: , it's, Matthew Walker ,, That's, GOP Sen, Marco Rubio, Rubio, Akinbolaji Organizations: Service, American Medical Association, DST, Sleep Research Society, National Conference of State Legislatures, Protection, GOP, Senate, University of Minnesota Medical School Locations: Germany, Europe, Hawaii, Arizona, Indiana, Finland, California
Phones and other devices will automatically tick forward one hour, and we'll lose an hour of sleep. But every year on the Monday after the switch, hospitals report a 24% spike in heart-attack visits around the US. "That's how fragile and susceptible your body is to even just one hour of lost sleep," sleep expert Matthew Walker, author of "How We Sleep," previously told Insider. iStock; InsiderThe reason that springing the clocks forward can kill us comes down to interrupted sleep schedules. Walker said daylight-saving time, or DST, is a kind of "global experiment" we perform twice a year.
It failed to meet its goal of non-inferiority compared to the conventional vaccine for the B/Victoria and B/Yamagata-lineage strains, the drugmaker said. "We have always said our goal is to produce a flu vaccine, and then to iterate it, and to fine tune it over time to really make it exceptional," Chief Medical Officer Paul Burton said in an interview. Seventy percent of those who received Moderna's shot reported mostly mild adverse reactions compared to 48% for the conventional flu vaccine. The company also has an ongoing late-stage efficacy study on the mRNA-1010 flu vaccine, which could have data within weeks. The flu, an infection of the nose, throat and lungs, kills 290,000 to 650,000 people worldwide annually.
CNN —An experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study. “We know that broadly neutralizing antibodies are a potentially effective strategy to prevent HIV,” del Rio said. “However, the incorporation of many different shots into an HIV vaccine regimen is unappealing. More than 20 HIV vaccine clinical trials are ongoing around the world, according to the International AIDS Vaccine Initiative. But having an HIV vaccine available would make protection against the virus more accessible, he said.
The results are based on blood samples taken from adults one week after they received the updated booster. The FDA also authorized Moderna's updated booster based on similarly limited data. The FDA authorized the updated shots based on studies in mice — plus human trial results from a similar booster that targets the original omicron strain, called BA.1. At the time, Dr. Peter Marks, the FDA's top vaccine regulator, said the agency hoped the updated vaccines will provide stronger protection against symptomatic disease than the older vaccines. Moderna didn't immediately respond to a request for comment about when it will release new data on its updated booster.
Total: 5